The company, founded in 2003 and based in Horsham, Pennsylvania, focuses on creating therapeutics for sleep apnea, ventilator weaning, anesthetic/analgesic-induced respiratory depression, COPD, obesity-hypoventilation syndrome, and other common diseases. Its neuro-respiratory medicines help patients overcome respiratory and breathing problems, providing a potential solution to a range of health issues.